CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16

    NEXT STORY
    Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer
    PREV STORY
    $5.3 Billion UV Disinfection Equipment Market by Component, Power Rating, Application, End-User, and Region – Global Forecast to 2025
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Nabriva Therapeutics Announces Completion of Enrollment in LEAP 2, a Phase 3 Clinical Trial Evaluating Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia in Adults

    DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Nabriva ...

    author_avatar
    NASDAQ Market News

    Oxford University breakthrough on global COVID-19 vaccine

    author_avatar
    NASDAQ Market News

    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company

    author_avatar
    NASDAQ Market News